IFTLD1 Antilichaam

IFTLD1 Antibody: The intermediate filament tail domain-containing protein (IFLTD1) was initially identified as a candidate gene for pulmonary adenoma susceptibility 1 gene in mice. Transcripts of the gene were only detected in mouse lung tissue from strains carrying the Pas1-susceptible allele. Expression of different alleles of this gene in lung cancer cell lines resulted in different levels of colony formation in in vitro colony formation assays, suggesting that allelic variants of this gene can modulate growth of human cancer cells.

160492

Q8N9Z9

NP_001139200

Human, Mouse, Rat

Unconjugated

Primary Antibodies

Cancer, Cell Cycle

IFTLD1 Antibody is affinity chromatography purified via peptide column.

Cat. No. 1462 - Rat Lung Tissue Lysate

1 mg/mL

IFTLD1 Antibody is supplied in PBS containing 0.02% sodium azide.

None

Blue Ice

IFTLD1 antibody can be stored at 4˚ C for three months and -20˚ C, stable for up to one year. As with all antibodies care should be taken to avoid repeated freeze thaw cycles. Antibodies should not be exposed to prolonged high temperatures.

IgG

At least four isoforms of IFLTD1 are known to exist; this antibody will detect all but isoform 4

IFLTD1

Intermediate filament tail domain containing 1

Homo sapiens

Wang M, Lemon WJ, Liu G, et al. Fine mapping and identification of candidate pulmonary adenoma susceptibility 1 genes using advanced intercross lines. Cancer Res. 2003; 63:3317-24.

Wang M, Futamura M, Wang Y, et al. Pasc1 is a candidate for the mouse pulmonary adenoma susceptibility 1 locus. Oncogene 2005; 24:1958-63.

Galbiati F, Pettinicchio A, Dragani TA, et al. Allelic effects of mouse Pas candidate genes in human lung cancer cell lines. Cancer Lett. 244:176-81.

IFTLD1 Antibody: PAS1C1, Intermediate filament tail domain-containing protein 1

ELISA, WB, IHC-P

224593273

Liquid